Ability Pharmaceuticals
PrivateLast Round
Early Funding
Mar 11, 2024
Est. Valuation
$31.43M
Total Funding Raised
$11.24M
Company Overview
Ability Pharmaceuticals, S.A. is a biopharmaceutical company that develops oral targeted anticancer compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ability Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Ability Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 11, 2024 | ||||
| Grant | Nov 21, 2022 | ||||
| Grant | Oct 7, 2022 | ||||
| VC Round | Mar 16, 2020 | ||||
| VC Round | Sep 12, 2019 | ||||
VC Round | Sep 21, 2012 |
Key People
Founding team and executive leadership
Carles Domenech
Executive Chairman And Chief Executive Officer, Executive Chairman And Chief Scientific Officer At Ability Pharmaceuticals, Chief Executive Officer VP Business Development And Licensing
Ability Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Early Funding |
| Inveready | VC Round, Early Funding |
| CTI Life Sciences Fund | Early Funding |
| CDTI Innvierte Program | Early Funding |
| NextGenerationEU | Grant |
| Fitalent | Early Funding |
| Capital Cell | Early Funding, VC Round |
Ability Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ability Pharmaceuticals's valuation, stock price, and market status.
